martes, 21 de noviembre de 2023
ABBV-552 for Early-Stage Alzheimer's Disease + CT1812 for Early-Stage Alzheimer's Disease + Therapeutic Plasma Exchange To Reduce Blood Biomarkers Linked to Alzheimer's Disease + Volunteers needed for studies to advance dementia research
ABBV-552 for Early-Stage Alzheimer's Disease
Volunteers needed for studies to advance dementia research
https://www.alzheimers.gov/clinical-trials/abbv-552-early-stage-alzheimers-disease?utm_source=nia-eblast&utm_medium=email&utm_campaign=clinicaltrials-20231120
CT1812 for Early-Stage Alzheimer's Disease
Volunteers needed for studies to advance dementia research
https://www.alzheimers.gov/clinical-trials/ct1812-early-stage-alzheimers-disease?utm_source=nia-eblast&utm_medium=email&utm_campaign=clinicaltrials-20231120
Therapeutic Plasma Exchange To Reduce Blood Biomarkers Linked to Alzheimer's Disease
Volunteers needed for studies to advance dementia research
https://www.alzheimers.gov/clinical-trials/therapeutic-plasma-exchange-reduce-blood-biomarkers-linked-alzheimers-disease?utm_source=nia-eblast&utm_medium=email&utm_campaign=clinicaltrials-20231120
Suscribirse a:
Enviar comentarios (Atom)
No hay comentarios:
Publicar un comentario